Dallas
Baylor Health Care System is constructing a 2,200-sf cell processing lab at Baylor University Medical Center in Dallas. The $2.4-million GMP facility will house custom cancer vaccine manufacturing operations for Baylor subsidiary ODC Therapies. Sited in the Zelig H. Lieberman Research Building, the facility will help ODC continue the clinical trial process for patients in late stage malignant melanoma. Baylor plans to develop a significantly larger facility that includes office and lab space for ODC and other companies within two years.
